Atrial Fibrillation Trial, Recruiting NCT06055751 Sponsor: Kansas City Heart Rhythm Research Foundation Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06055751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People over 18 years of age who have severe narrowing of the heart's aortic valve (aortic stenosis) and have had a procedure called TAVI (a non-surgical way to replace the aortic valve)
  • People who developed a new or worsened electrical conduction problem in their heart, detected on a heart tracing (ECG) taken immediately after the TAVI procedure — specifically, one of the following: a new left bundle branch block, a new or worsened first degree AV block, a new right bundle branch block, or a temporary higher-grade AV block that resolved on its own within 24 hours (confirm with trial site if unsure which applies)
  • People who have already had a small heart monitor (called an insertable loop recorder, or ILR) placed under the skin to track these heart rhythm changes over time

Who may not be able to join:

  • People who developed a serious heart rhythm block after TAVI that required an urgent pacemaker to be fitted
  • People who already have an existing implanted heart device (such as a pacemaker or defibrillator)
  • People who have a medical condition that means a small device inserted under the skin long-term would not be safe or appropriate for them
  • People who are currently pregnant, confirmed by a urine pregnancy test (this test is done for all women who could potentially be pregnant)
  • People who are not willing to sign the consent form, do not have the ability to give consent, or who withdraw their consent after signing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Naga Venkata K. Pothineni, MD, Kansas City Heart Rhythm Institute

Phone: 816-651-1969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kansas City Heart Rhythm Research Foundation
Registry
ClinicalTrials.gov
Start date
22 September 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of brady arrhythmias; Predictors of development of late onset heart block needing pacing; New onset Atrial Fibrillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov